| Field | Row 1 |
|---|---|
| adsh | 0001829126-25-003926 |
| cik | 2009183 |
| name | TITAN ACQUISITION CORP. |
| sic | 6770 |
| countryba | US |
| stprba | TX |
| cityba | HOUSTON |
| zipba | 77002 |
| bas1 | C/O WINSTON & STRAWN LLP |
| bas2 | 800 CAPITOL ST., STE 2400 |
| baph | 3477204333 |
| countryma | US |
| stprma | TX |
| cityma | HOUSTON |
| zipma | 77002 |
| mas1 | C/O WINSTON & STRAWN LLP |
| mas2 | 800 CAPITOL ST., STE 2400 |
| countryinc | KY |
| stprinc | |
| ein | 000000000 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250523 |
| accepted | 2025-05-23 17:14:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | titanacq_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001829126-25-003926 | 20241231 | Additional Paid In Capital | 24310.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -17.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Common Stock Shares Issued | 6900000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Common Stock Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Due To Sponsor | 74200.0000 | USD | 0 | 0001829126-25-003926 | |||
| 0001829126-25-003926 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 78200.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Net Cash Provided By Used In Operating Activities | -17.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Notes Assumed1 | 300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Other Accrued Liabilities Current | 320330.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20250331 | Retained Earnings Accumulated Deficit | -331532.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Class A Ordinary Shares; | During 2024, the Company issued 7,475,000 Class B ordinary shares on January 24. On August 5, 2024, the Company forfeited 1,150,000 Founder Shares for no consideration resulting in the Sponsor holding a total of 6,325,000 Class B ordinary shares. On March 4, 2025, the Company issued an additional 575,000 Founder Shares for no consideration, resulting in the sponsor holding an aggregate of 6,900,000 Class B ordinary shares. On April 10, 2025, the underwriters fully exercised their over-allotment option, rele | ||
| 0001829126-25-003926 | 20240331 | Stockholders Equity | -78217.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003926 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Stockholders Equity | 24310.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003926 | 20241231 | Accounts Payable And Accrued Liabilities Current | 44040.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Cash And Cash Equivalents At Carrying Value | 25000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 25000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Common Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20231231 | Common Stock Shares Issued | 7475000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Deferred Offering Costs | 484258.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Earnings Per Share Basic | -0.0100 | USD | 1 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20240331 | Issuance Of Class B Ordinary Shares To Sponsor | USD | 1 | 0001829126-25-003926 | Equity Components= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20241231 | Liabilities And Stockholders Equity | 345330.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Liabilities Current | 815773.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-003926 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Net Income Loss | -78292.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20250331 | Stockholders Equity | -306532.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Assets | 345330.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Due To Related Party | 135000.0000 | USD | 0 | 0001829126-25-003926 | |||
| 0001829126-25-003926 | 20250331 | Due To Related Party | 169849.0000 | USD | 0 | 0001829126-25-003926 | |||
| 0001829126-25-003926 | 20250331 | Due To Sponsor | 238634.0000 | USD | 0 | 0001829126-25-003926 | |||
| 0001829126-25-003926 | 20250331 | Increase Decrease In Deferred Charges | 183608.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Liabilities Current | 573570.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20240331 | Net Income Loss | -78217.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003926 | 20241231 | Retained Earnings Accumulated Deficit | -253240.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20240331 | Stockholders Equity | -53217.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Accounts Payable And Accrued Liabilities Current | 107290.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Assets Current | 25000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 24983.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Common Stock Value | 690.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Deferred Offering Costs | 320330.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | General And Administrative Expense | 78217.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 98099.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Issuance Of Class B Ordinary Shares To Sponsor | 690.0000 | USD | 1 | 0001829126-25-003926 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Net Cash Provided By Used In Operating Activities | -17.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20240331 | Notes Assumed1 | 161579.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Stockholders Equity | 690.0000 | USD | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Stockholders Equity | -228240.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Stockholders Equity | 690.0000 | USD | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Stockholders Equity | -331532.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003926 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6000000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | During 2024, the Company issued 7,475,000 Class B ordinary shares on January 24. On August 5, 2024, the Company forfeited 1,150,000 Founder Shares for no consideration resulting in the Sponsor holding a total of 6,325,000 Class B ordinary shares. On March 4, 2025, the Company issued an additional 575,000 Founder Shares for no consideration, resulting in the Sponsor holding an aggregate of 6,900,000 Class B ordinary shares. On April 10, 2025, the underwriters fully exercised their over-allotment option, rele | |
| 0001829126-25-003926 | 20250331 | Cash And Cash Equivalents At Carrying Value | 24983.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Common Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Common Stock Value | USD | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20240331 | Earnings Per Share Basic | -0.0100 | USD | 1 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20240331 | Increase Decrease In Other Accounts Payable | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20240331 | Issuance Of Class B Ordinary Shares To Sponsor | 25000.0000 | USD | 1 | 0001829126-25-003926 | |||
| 0001829126-25-003926 | 20240331 | Net Cash Provided By Used In Financing Activities | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-003926 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Preferred Stock Shares Authorized | 1000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20231231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | |||
| 0001829126-25-003926 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Additional Paid In Capital | 24310.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 24983.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Common Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20231231 | Common Stock Shares Outstanding | 7475000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Common Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | General And Administrative Expense | 78292.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Increase Decrease In Deferred Charges | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20240331 | Issuance Of Class B Ordinary Shares To Sponsor | 24310.0000 | USD | 1 | 0001829126-25-003926 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003926 | 20240331 | Issuance Of Class B Ordinary Shares To Sponsor Shares | 6900000.0000 | shares | 1 | 0001829126-25-003926 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20240331 | Net Income Loss | -78217.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Other Accrued Liabilities Current | 300000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20240331 | Proceeds From Issuance Of Common Stock | 25000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Stockholders Equity | -253240.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003926 | 20250331 | Assets | 509241.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 24983.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Common Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Common Stock Value | USD | 0 | us-gaap/2024 | Class Of Stock= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Common Stock Value | 690.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | During 2024, the Company issued 7,475,000 Class B ordinary shares on January 24. On August 5, 2024, the Company forfeited 1,150,000 Founder Shares for no consideration resulting in the Sponsor holding a total of 6,325,000 Class B ordinary shares. On March 4, 2025, the Company issued an additional 575,000 Founder Shares for no consideration, resulting in the Sponsor holding an aggregate of 6,900,000 Class B ordinary shares. On April 10, 2025, the underwriters fully exercised their over-allotment option, rele | |
| 0001829126-25-003926 | 20250331 | Due To Related Party | 165000.0000 | USD | 0 | 0001829126-25-003926 | Related Party Transactions By Related Party= President; | ||
| 0001829126-25-003926 | 20250331 | Increase Decrease In Other Accounts Payable | 163784.0000 | USD | 1 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Net Income Loss | -78292.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001829126-25-003926 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001829126-25-003926 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Stockholders Equity | 690.0000 | USD | 0 | us-gaap/2024 | Equity Components= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 6000000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 6000000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Assets Current | 24983.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20250331 | Common Stock Shares Issued | 6900000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20250331 | Common Stock Shares Outstanding | 6900000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; | ||
| 0001829126-25-003926 | 20241231 | Due To Related Party | 135000.0000 | USD | 0 | 0001829126-25-003926 | Related Party Transactions By Related Party= President; | ||
| 0001829126-25-003926 | 20240331 | Issuance Of Class B Ordinary Shares To Sponsor | USD | 1 | 0001829126-25-003926 | Equity Components= Retained Earnings; | |||
| 0001829126-25-003926 | 20250331 | Liabilities And Stockholders Equity | 509241.0000 | USD | 0 | us-gaap/2024 | |||
| 0001829126-25-003926 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20250331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2024 | ||||
| 0001829126-25-003926 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001829126-25-003926 | 20240331 | Stockholders Equity | 24310.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003926 | 20241231 | Stockholders Equity | 24310.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001829126-25-003926 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Class A Ordinary Shares; | |||
| 0001829126-25-003926 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6000000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Class B Ordinary Shares; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Issuance Of Class B Ordinary Shares To Sponsor | 0001829126-25-003926 | 1 | 0 | monetary | D | D | Issuance of Class B ordinary shares to Sponsor | |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Notes Assumed1 | us-gaap/2024 | 0 | 0 | monetary | D | C | Notes Assumed | The fair value of notes assumed in noncash investing or financing activities. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Issuance Of Class B Ordinary Shares To Sponsor Shares | 0001829126-25-003926 | 1 | 0 | shares | D | Issuance of Class B ordinary shares to Sponsor, shares | ||
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Due To Related Party | 0001829126-25-003926 | 1 | 0 | monetary | I | C | Due to related party | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Increase Decrease In Deferred Charges | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Deferred Charges | The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Due To Sponsor | 0001829126-25-003926 | 1 | 0 | monetary | I | C | Due to sponsor | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Deferred Offering Costs | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Offering Costs | Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Other Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Increase Decrease In Other Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Accounts Payable | Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001829126-25-003926 | 2 | 9 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash | 0 |
| 0001829126-25-003926 | 2 | 10 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001829126-25-003926 | 2 | 11 | BS | 0 | H | Deferred Offering Costs | us-gaap/2024 | Deferred offering costs associated with proposed public offering | 0 |
| 0001829126-25-003926 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001829126-25-003926 | 2 | 14 | BS | 0 | H | Other Accrued Liabilities Current | us-gaap/2024 | Accrued offering expenses | 0 |
| 0001829126-25-003926 | 2 | 15 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001829126-25-003926 | 2 | 16 | BS | 0 | H | Due To Related Party | 0001829126-25-003926 | Due to related party | 0 |
| 0001829126-25-003926 | 2 | 17 | BS | 0 | H | Due To Sponsor | 0001829126-25-003926 | Due to sponsor | 0 |
| 0001829126-25-003926 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Liabilities | 0 |
| 0001829126-25-003926 | 2 | 21 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2025, and December 31, 2024 | 0 |
| 0001829126-25-003926 | 2 | 22 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock value | 0 |
| 0001829126-25-003926 | 2 | 23 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001829126-25-003926 | 2 | 24 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001829126-25-003926 | 2 | 25 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders deficit | 0 |
| 0001829126-25-003926 | 2 | 26 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Shareholders Deficit | 0 |
| 0001829126-25-003926 | 3 | 7 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preference stock, par value | 0 |
| 0001829126-25-003926 | 3 | 8 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preference stock, shares authorized | 0 |
| 0001829126-25-003926 | 3 | 9 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preference stock, shares issued | 0 |
| 0001829126-25-003926 | 3 | 10 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preference stock, shares outstanding | 0 |
| 0001829126-25-003926 | 3 | 11 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001829126-25-003926 | 3 | 12 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001829126-25-003926 | 3 | 13 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock shares, issued | 0 |
| 0001829126-25-003926 | 3 | 14 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock shares, outstanding | 0 |
| 0001829126-25-003926 | 4 | 6 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001829126-25-003926 | 4 | 7 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-003926 | 4 | 8 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding, basic | 0 |
| 0001829126-25-003926 | 4 | 9 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding, diluted | 0 |
| 0001829126-25-003926 | 4 | 10 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per ordinary share | 0 |
| 0001829126-25-003926 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance January 11, 2024 (inception) | 0 |
| 0001829126-25-003926 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, shares | 0 |
| 0001829126-25-003926 | 5 | 11 | EQ | 0 | H | Issuance Of Class B Ordinary Shares To Sponsor | 0001829126-25-003926 | Issuance of Class B ordinary shares to Sponsor | 0 |
| 0001829126-25-003926 | 5 | 12 | EQ | 0 | H | Issuance Of Class B Ordinary Shares To Sponsor Shares | 0001829126-25-003926 | Issuance of Class B ordinary shares to Sponsor, shares | 0 |
| 0001829126-25-003926 | 5 | 13 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-003926 | 5 | 14 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance March 31, 2024 (unaudited) | 0 |
| 0001829126-25-003926 | 5 | 15 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, shares | 0 |
| 0001829126-25-003926 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001829126-25-003926 | 6 | 4 | CF | 0 | H | Increase Decrease In Other Accounts Payable | us-gaap/2024 | Increase in payable to sponsor | 0 |
| 0001829126-25-003926 | 6 | 5 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Increase in accounts payable and accrued expenses | 0 |
| 0001829126-25-003926 | 6 | 6 | CF | 0 | H | Increase Decrease In Deferred Charges | us-gaap/2024 | Deferred offering costs | 1 |
| 0001829126-25-003926 | 6 | 7 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001829126-25-003926 | 6 | 9 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Issuance of Class B ordinary shares to sponsor | 0 |
| 0001829126-25-003926 | 6 | 10 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001829126-25-003926 | 6 | 11 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash | 0 |
| 0001829126-25-003926 | 6 | 12 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash beginning of the period | 0 |
| 0001829126-25-003926 | 6 | 13 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash end of the period | 0 |
| 0001829126-25-003926 | 6 | 15 | CF | 0 | H | Notes Assumed1 | us-gaap/2024 | Deferred offering costs included in accrued offering expenses | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |